Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Interest & Investment Income (2018 - 2025)

Dna X filings provide 7 years of Interest & Investment Income readings, the most recent being -$484000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 3933.33% to -$484000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.5 million, a 4403.03% decrease, with the full-year FY2025 number at -$1.5 million, down 5024.14% from a year prior.
  • Interest & Investment Income hit -$484000.0 in Q4 2025 for Dna X, up from -$522000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of -$1000.0 in Q4 2022 to a low of -$522000.0 in Q3 2025.
  • Median Interest & Investment Income over the past 4 years was -$22000.0 (2022), compared with a mean of -$125153.8.
  • Biggest five-year swings in Interest & Investment Income: surged 85.71% in 2023 and later tumbled 3933.33% in 2025.
  • Dna X's Interest & Investment Income stood at -$1000.0 in 2022, then plummeted by 300.0% to -$4000.0 in 2023, then tumbled by 200.0% to -$12000.0 in 2024, then tumbled by 3933.33% to -$484000.0 in 2025.
  • The last three reported values for Interest & Investment Income were -$484000.0 (Q4 2025), -$522000.0 (Q3 2025), and -$389000.0 (Q2 2025) per Business Quant data.